Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients

BMC Cancer

Table 1 An overview of clinical parameters in a set of patients with repeatedly resected gliomas.TU size (mm) = tumor size before surgery; RT dose = radiotherapy dose

sample	resection	age	histology dg.	Survival (months)	sex	RT dose	TMZ dose concomitant	TMZ dose adjuvant/number of cycles	TU size (mm)	TU location	IDH1 status
Le	1st	57	giant-cell glioblastoma	49	F	NO	NO	NO	50	parietal	wt
	2nd	58	dtto + postsurgical changes						16	parietal	wt
	3rd	59	dtto						40	parietal	wt
	4th	60	dtto						34	parietal	wt
Pu	1st	61	prim.gbm	44	M	60 Gy	160	400/6	20	temporal	wt
	2nd	62	gbm perzistence, postsurgical changes			13 Gy (gamma knife)			15	temporal	wt
	3rd	64	postsurgical changes, gbm infiltration						16	temporal	wt
Ku	1st	26	prim.gbm	55	M	60 Gy	-	-	37	tempoparietal	mt
	2nd	28	gbm reccurence, postsurgical changes						54	tempoparietal	mt
Do	1st	58	prim.gbm	31	F	60 Gy	140	300/12	25	frontal	wt
	2nd	61	reccurence						35	frontal	wt
Jo	1st	63	prim.gbm	36	F	60 Gy	140	NO	36	parietal	wt
	2nd	65	reccurence, postsurgical changes			12 Gy (gamma knife			36	parietal	wt
Du	1st	62	prim.gbm	34	M	60 Gy	140	300/6	53	frontal	wt
	2nd	64	gbm persistance						48	frontal	wt
Bi	1st	67	prim.gbm	24	F	60 Gy	140	NO	38	temporal	wt
	2nd	69	gbm reccurence						53	temporal	wt
Na	1st	38	prim.gbm	48	M	60 Gy	140	400/6	72	parietal	mt
	2nd	41	gbm reccurence			24 Gy (gamma knife)			34	parietal	mt

ISSN: 1471-2407